Intellia Therapeutics, Inc.

Some of the best links we picked up around the internet

FDA Clears First CRISPR-Cas13 RNA-Editing Trial...

Nov. 6, 2024

The FDA has cleared HuidaGene Therapeutics' investigational new drug application for HG202, the first CRISPR-Cas13 RNA-editing therapy to enter...

CMN Weekly (25 October 2024) - Your Weekly CRISPR...

CMN Weekly

Oct. 25, 2024

Some of the best links we picked up around the internet

The Latest Updates From the Gene-Editing Clinical...

CMN Clinical

Oct. 9, 2024

In this clinical update, we bring you the latest news from four gene-editing trials sponsored by RenJi Hospital (Shanghai), The University of Texas MD...

CMN Weekly (13 September 2024) - Your Weekly...

CMN Weekly

Sep. 13, 2024

Some of the best links we picked up around the internet

CMN Weekly (9 August 2024) - Your Weekly CRISPR...

CMN Weekly

Aug. 9, 2024

Some of the best links we picked up around the internet

CMN Weekly (2 August 2024) - Your Weekly CRISPR...

CMN Weekly

Aug. 2, 2024

Some of the best links we picked up around the internet

Intellia Obtains UK Clearance to Begin Gene...

CMN Clinical

Jul. 31, 2024

Intellia Therapeutics announced yesterday that the UK’s Medicine and Healthcare products Regulatory Agency has cleared its clinical trial application...